Post-hematopoietic stem cell transplantion immune-mediated cytopenias

Immunotherapy

Volumn 1, Issue 1, 2009, Pages 39-47

  Tsirigotis, Panagiotis D ^a   Resnick, Igor B ^a   Or, Reuven ^a   Elad, Sharon ^a   Zilberman, Irina ^a   Yoffe, Luba ^a   Levovic, Alexander ^a   Miron, Svetlana ^a   Gesundheit, Benjamin ^a   Slavin, Shimon ^a   Shapira, Michael Yechiel ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Allogeneic bone marrow transplantation; Aplasia; Graft versus host disease; Immune dysregulation; Neutropenia; Thrombocytopenia

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CASE REPORT; CYTOPENIA; DIFFERENTIAL DIAGNOSIS; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPATHOGENESIS; MALE; MEGAKARYOPOIESIS; PANCYTOPENIA; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADULT; AGED; BONE MARROW; CHIMERISM; CYCLOSPORINE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LEUKEMIA, MYELOID, ACUTE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEUTROPENIA; POSTOPERATIVE COMPLICATIONS; RED-CELL APLASIA, PURE; REMISSION INDUCTION; THROMBOCYTOPENIA; TRANSPLANTATION CONDITIONING;

EID: 77953453937     PISSN: 1750743X     EISSN: None     Source Type: Journal    
DOI: 10.2217/1750743X.1.1.39     Document Type: Article

References (42)

1. Sherer Y, Shoenfeld Y: Autoimmune diseases and autoimmunity post bone marrow transplantation. Bone Marrow Transplant. 22, 873-881 (1998). (Pubitemid 28499360)
2. Bolger GB, Sullivan KM, Spence AM et al.: Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft versus host disease. Neurology 36, 1087-1091 (1986).
3. Mackey JR, Desai S, Larratt L et al.: Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of the literature. Bone Marrow Transplant. 19, 939-942 (1997). (Pubitemid 27217663)
4. Lampeter EF, Homberg M, Quabeck K et al.: Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341, 1243-1244 (1993). (Pubitemid 23146932)
5. Aldouri MA, Ruggier R, Epstein O et al.: Adoptive transfer of hyperthyroidism and autoimmune thyroiditis following allogeneic bone marrow transplantation for chronic myeloid leukemia. Br. J. Haematol. 74, 118-120 (1990).
6. Minchinton RM, Waters AH, Kendra J et al.: Autoimmune thrombocytopenia acquired from an allogeneic bone-marrow graft. Lancet 2, 627-629 (1982). (Pubitemid 12056644)
7. Ferrara JLM, Deeg HJ: Graft versus host disease. N. Engl. J. Med. 324, 667-674 (1991).
8. Parkman R: Is chronic graft versus host disease an autoimmune disease? Curr. Opin. Immunol. 5, 800-803 (1993).
9. Haynes BF, Markert ML, Sempowski GD et al.: The role of thymous in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu. Rev. Immunol. 18, 529-560 (2000).
10. Wils EJ, Cornelissen JJ: Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvement. Blood Rev. 19, 89-98 (2005).
11. + regulatory T cells and graft-versus-host disease. Semin. Hematol. 43, 62-69 (2006).
12. Slavin S, Nagler A, Naparstek E et al.: Non myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non malignant hematologic diseases. Blood 91, 756-763 (1998). ■■ First clinical trial evaluating feasibility and efficacy of nonmyeloablative hematopoietic stem cell transplantation (SCT). (Pubitemid 28078275)
13. Sniecinski IJ, O'Donnell MR: Hemolytic complications of hematopoietic cell transplantation. In: Hematopoietic Cell Transplantation. Thomas ED, Blume KG, Forman SJ (Eds). Blackwell Science, Oxford, UK 674-684 (1999).
14. Klumpp TR, Block CC, Caligiuri MA et al.: Immune mediated cytopenia following bone marrow transplantation: case reports and review of the literature. Medicine 71, 73-84 (1992).
15. Klumpp TR: Immunohematologic complications of bone marrow transplantation. Bone Marrow Transplant. 8, 159-170 (1991).
16. O'Brien TA, Eastlund T, Peters C et al.: Autoimmune haemolytic anemia complicating haemopoietic cell transplantation in pediatric patients: high incidence and significant mortality in unrelated donors for non-malignant diseases. Br. J. Haematol. 127, 67-75 (2004). ■■ Retrospective study, significant information regarding the incidence, prognosis, and treatment outcome of autoimmune hemolytic anemia after allo-SCT in pediatric patients.
17. Klumpp TR, Herman JH: Autoimmune neutropenia after bone marrow transplantation. Blood 82, 1035-1038 (1993).
18. Raj K, Narayanan S, Augustson B et al.: Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation. Bone Marrow Transplant. 35, 299-301 (2005). ■■ Efficacy of rituximab in the treatment of autoimmune cytopenias in patients after allo-SCT. (Pubitemid 40268303)
19. Hartert A, Willenbacher W, Gunzelmann S et al.: Successful treatment of thrombocytopenia and hemolytic anemia with IvIG in a patient with lupus-like syndrome after mismatched related PBSCT. Bone Marrow Transplant. 27, 337-340 (2001). (Pubitemid 32177937)
20. De Lord C, Marsh JC, Smith JG et al.: Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anemia. Bone Marrow Transplant. 18, 237-239 (1996). ■ Interesting case of autoimmune cytopenias. (Pubitemid 26289665)
21. Bashey A, Owen I, Lucas GF et al.: Late onset immune pancytopenia following bone marrow transplantation. Br. J. Haematol. 78, 268-274 (1991). ■ Interesing case of autoimmune cytopenias.
22. Klumpp TR, Caligiuri MA, Rabinowe SN et al.: Autoimmune pancytopenia following allogeneic bone marrow transplantation. Bone Marrow Transplant. 6, 445-447 (1990). ■ Interesting case of autoimmune cytopenias.
23. Marinone G, Roncoli B, Marinone M: Pure white cell aplasia. Semin. Hematol. 28, 298-307 (1998).
24. Tsirigotis P, Veneris E, Kapsimali V et al.: 2-deoxycoformycin in the treatment of T-large granular lymphocytic leukemia. Leuk. Res. 27, 865-867 (2003).
25. Slavin S, Naparstek E, Nagler A et al.: Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 87, 2195-2204 (1996). (Pubitemid 26086858)
26. Worel N, Greinix HT, Schneider B et al.: Regeneration of erythropoiesis after related and unrelated-donor BMT or peripheral HPC transplantation. A major ABO mismatch means problems. Transfusion 40, 543-550 (2000).
27. Stussi G, Muntwyler J, Passweg JR et al.: Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 30, 87-93 (2002). (Pubitemid 34906091)
28. Badros A, Tricot G, Toor A et al.: ABO mismatch may affect engraftment in multiple myeloma patients receiving non-myeloablative conditioning. Transfusion 42, 205-209 (2002). ■ Significant data regarding the association between ABO mismatch and engraftment.
29. Ockelford PA, Hill RS, Nelson L et al.: Serological complications of a major ABO incompatible bone marrow transplantation in a Polynesian with aplastic anemia. Transfusion 22, 62-65 (1982).
30. Blacklock HA, Katz F, Michalevicz R et al.: A and B blood group antigen expression on mixed colony cells and erythroid precursors: relevance for human allogeneic bone marrow transplantation. Br. J. Haematol. 58, 267-276 (1984).
31. Chen J, Lipovsky K, Ellison FM et al.: Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion induced bone marrow failure. Blood 104, 1671-1678 (2004). (Pubitemid 39202273)
32. Marijt WA, Kernan NA, Diaz-Barientos T et al.: Multiple minor histocompatibility antigen specific cytotoxic T-lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation. Bone Marrow Transplant. 16, 125-132 (1995).
33. Grigoriadou K, Menard C, Perarnan B et al.: MHC class Ia molecules alone control NK-mediated bone marrow graft rejection. Eur. J. Immunol. 29, 3683-3690 (1999).
34. Bader P, Niethammer D, Willasch A et al.: How and when should we monitor chimerism after allogeneic stem cell transplantation. Bone Marrow Transplant. 35, 107-119 (2005). ■■ Excellent review, indications and interpretation of chimerism monitoring. (Pubitemid 40185924)
35. Wolff SN: Second hemopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant. 29, 545-552 (2002).
36. Woodard P, Tong X, Richardson S et al.: Etiology and outcome of graft failure in Pediatric hematopoietic stem cell transplant recipients. J. Pediatr. Hematol. Oncol. 25, 955-959 (2003).
37. Lee KH, Lee JH, Choi SJ et al.: Failure of trilineage blood cell reconstitution after initial neutrophil engraftment in patients undergoing allogeneic hematopoietic cell transplantation - frequency and outcomes. Bone Marrow Transplant. 33, 729-734 (2004).
38. Novotny JR, Rosenthal C, Elmaagacli AH et al.: Disease or therapy related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation. Eur. J. Haematol. 73, 1-9 (2004).
39. Aizawa S, Nakano M, Iwase O et al.: Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro. Leuk. Res. 23, 239-246 (1999).
40. Gurevitch O, Kurkalli BGS, Prigozhina T et al.: Reconstitution of cartilage, bone, and hematopoietic microenvironment with deminaralized bone matrix and bone marrow cells. Stem Cells 21, 588-597 (2003). ■ Reconstitution of hematopoietic microenvironment is feasible. Preclinical study. (Pubitemid 37444115)
41. Steffens HP, Podlech J, Kurz S et al.: Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. J. Virol. 72, 5006-5015 (1998). (Pubitemid 28215681)
42. Johnston RE, Geretti AM, Prentice HG et al.: HHV-6 related secondary graft failure following allogeneic bone marrow transplantation. Br. J. Haematol. 105, 1041-1043 (1999).